PTC THERAPEUTICS, INC. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4PTC THERAPEUTICS, INC.PTCT2d

   PTC Therapeutics, Inc. shares sold

   • SCHMERTZLER MICHAEL sold 2,118 shares on 10/14/2026
   • SCHMERTZLER MICHAEL sold 382 shares on 10/14/2026
   • Shares sold at $59.52 and $60.14 per share

   Michael Schmertzler, reporting

2. ROUTINE4PTC THERAPEUTICS, INC.PTCT5d

   Boulding Mark Elliott filed Form 4

   • Filed on 2026-10-13
   • Sold 192 shares at $64.26
   • Purchased 192 shares at $39.42

   Mark Elliott Boulding, reporting

3. ROUTINE4PTC THERAPEUTICS, INC.PTCTOct 9

   PTC THERAPEUTICS, INC. insider sold shares

   • Michael Schmertzler sold 2,447 shares on 10/07/2026
   • Sold at $63.38 per share
   • Sold 53 shares on 10/07/2026 at $63.95

   Michael Schmertzler, reporting

4. ROUTINE144PTC THERAPEUTICS, INC.PTCTOct 9

   PTC THERAPEUTICS, INC. files Form 144

   • Filer CIK: 0001578852
   • Sale of 192 shares on 10/09/2026
   • Mark Boulding is the person for whose account the securities are sold

   Mark Elliott Boulding, reporting

5. ROUTINE144PTC THERAPEUTICS, INC.PTCTOct 8

   PTC THERAPEUTICS, INC. files Form 144

   • Filer: Section Six Partners, L.P.
   • 10,000 shares to be sold
   • Date of sale: 10/07/2026

   Michael Schmertzler, reporting

6. ROUTINE4PTC THERAPEUTICS, INC.PTCTOct 8

   PTC Therapeutics: Boulding buys and sells stock

   • 10/05/2026: Bought 1,638 shares at $39.42
   • 10/05/2026: Sold 1,638 shares at $64.03
   • 10/06/2026: Bought 435 shares at $39.42

   Mark Elliott Boulding, reporting

7. ROUTINE144PTC THERAPEUTICS, INC.PTCTOct 8

   PTC Therapeutics, Inc. - Mark Elliott sells shares

   • 435 shares sold on 10/06/2026
   • Aggregate market value $27,907.59
   • Sold 5,079 shares in July 2026

   Mark Elliott Boulding, reporting

8. ROUTINE144PTC THERAPEUTICS, INC.PTCTOct 5

   PTC Therapeutics, Inc. - Mark Elliott sells shares

   • Filer: Boulding Mark Elliott
   • 1638 shares to be sold
   • Aggregate market value: $104,883.45

   Mark Elliott Boulding

9. ROUTINE4PTC THERAPEUTICS, INC.PTCTOct 2

   PTC THERAPEUTICS, INC. reports stock transactions

   • Steele Glenn Jr MD PhD sold 12,000 shares at $65.16
   • Steele Glenn Jr MD PhD bought 12,000 shares at $11.23
   • Beneficial ownership dropped to 22,500 shares

   Glenn Jr Md Steele Phd

10. ROUTINE144PTC THERAPEUTICS, INC.PTCTSep 30

    STEELE GLENN JR MD PHD, planned sale of PTCT shares

    Glenn Jr Md Steele Phd, reporting

11. ROUTINE8-KPTC THERAPEUTICS, INC.PTCTSep 21

    Current report

12. ROUTINE4PTC THERAPEUTICS, INC.PTCTSep 18

    Michael Schmertzler, insider filing for PTCT

    Michael Schmertzler, reporting

13. ROUTINE4PTC THERAPEUTICS, INC.PTCTSep 11

    Michael Schmertzler, insider filing for PTCT

    Michael Schmertzler, reporting

14. ROUTINE144PTC THERAPEUTICS, INC.PTCTSep 9

    Michael Schmertzler, planned sale of PTCT shares

    Michael Schmertzler, reporting

15. ROUTINE4PTC THERAPEUTICS, INC.PTCTAug 28

    Michael Schmertzler, insider filing for PTCT

    Michael Schmertzler, reporting

16. ROUTINE8-KPTC THERAPEUTICS, INC.PTCTAug 28

    Current report

17. ROUTINE144/APTC THERAPEUTICS, INC.PTCTAug 25

    Michael Schmertzler, planned sale of PTCT shares (amended)

    Michael Schmertzler, reporting

18. ROUTINE4PTC THERAPEUTICS, INC.PTCTAug 21

    Michael Schmertzler, insider filing for PTCT

    Michael Schmertzler, reporting

19. ROUTINE4PTC THERAPEUTICS, INC.PTCTAug 19

    Mark Elliott Boulding, insider filing for PTCT

    Mark Elliott Boulding, reporting

20. ROUTINE144PTC THERAPEUTICS, INC.PTCTAug 19

    Michael Schmertzler, planned sale of PTCT shares

    Michael Schmertzler, reporting

21. ROUTINE144PTC THERAPEUTICS, INC.PTCTAug 17

    Mark Elliott Boulding, planned sale of PTCT shares

    Mark Elliott Boulding, reporting

22. ROUTINE8-KPTC THERAPEUTICS, INC.PTCTAug 13

    Current report

23. ROUTINE4PTC THERAPEUTICS, INC.PTCTAug 6

    Matthew B. Klein, insider filing for PTCT

    Matthew B. Klein, reporting

24. ROUTINE144PTC THERAPEUTICS, INC.PTCTAug 4

    Matthew B. Klein, planned sale of PTCT shares

    Matthew B. Klein, reporting

25. ROUTINE4PTC THERAPEUTICS, INC.PTCTJul 30

    2 insider filings

    Hege Elisabeth Sollie-Zetlmayer, insider filing for PTCT

    Show all 2

    • 4Insider filing for PTCTJul 30
    • 3New insider at PTCTJul 30

    Hege Elisabeth Sollie-Zetlmayer, reporting

26. NOTABLE10-QPTC THERAPEUTICS, INC.PTCTJul 30

    Quarterly report

27. ROUTINE8-KPTC THERAPEUTICS, INC.PTCTJul 30

    Current report

28. ROUTINE4PTC THERAPEUTICS, INC.PTCTJul 16

    Pierre Gravier, insider filing for PTCT

    Pierre Gravier, reporting

29. ROUTINE144PTC THERAPEUTICS, INC.PTCTJul 14

    Pierre Gravier, planned sale of PTCT shares

    Pierre Gravier, reporting

30. ROUTINE4PTC THERAPEUTICS, INC.PTCTJul 13

    2 insider filings

    Neil Gregory Almstead, insider filing for PTCT

    Show all 2

    • 4Insider filing for PTCTJul 13
    • 4Insider filing for PTCTJul 13

    Neil Gregory Almstead, reporting

31. ROUTINE144PTC THERAPEUTICS, INC.PTCTJul 9

    Neil Gregory Almstead, planned sale of PTCT shares

    Neil Gregory Almstead, reporting

32. ROUTINE144PTC THERAPEUTICS, INC.PTCTJul 9

    Mary L. Smith, planned sale of PTCT shares

    Mary L. Smith, reporting

33. ROUTINE4PTC THERAPEUTICS, INC.PTCTJul 8

    2 insider filings

    Mark Elliott Boulding, insider filing for PTCT

    Show all 2

    • 4Insider filing for PTCTJul 8
    • 4Insider filing for PTCTJul 8

    Mark Elliott Boulding, reporting

34. ROUTINE144PTC THERAPEUTICS, INC.PTCTJul 7

    Neil Gregory Almstead, planned sale of PTCT shares

    Neil Gregory Almstead, reporting

35. ROUTINE144PTC THERAPEUTICS, INC.PTCTJul 6

    2 Form 144 notices

    Neil Gregory Almstead, planned sale of PTCT shares

    Show all 2

    • 144Planned insider sale of PTCT sharesJul 6
    • 144Planned insider sale of PTCT sharesJul 6

    Neil Gregory Almstead, reporting

36. ROUTINE4PTC THERAPEUTICS, INC.PTCTJun 30

    Neil Gregory Almstead, insider filing for PTCT

    Neil Gregory Almstead, reporting

37. ROUTINE4PTC THERAPEUTICS, INC.PTCTJun 26

    Neil Gregory Almstead, insider filing for PTCT

    Neil Gregory Almstead, reporting

38. ROUTINE144PTC THERAPEUTICS, INC.PTCTJun 26

    Neil Gregory Almstead, planned sale of PTCT shares

    Neil Gregory Almstead, reporting

39. ROUTINE144PTC THERAPEUTICS, INC.PTCTJun 25

    Neil Gregory Almstead, planned sale of PTCT shares

    Neil Gregory Almstead, reporting

40. ROUTINE4PTC THERAPEUTICS, INC.PTCTJun 24

    Neil Gregory Almstead, insider filing for PTCT

    Neil Gregory Almstead, reporting

41. ROUTINE144PTC THERAPEUTICS, INC.PTCTJun 24

    Neil Gregory Almstead, planned sale of PTCT shares

    Neil Gregory Almstead, reporting

42. ROUTINE4PTC THERAPEUTICS, INC.PTCTJun 22

    2 insider filings

    Christine Marie Utter, insider filing for PTCT

    Show all 2

    • 4Insider filing for PTCTJun 22
    • 4Insider filing for PTCTJun 22

    Christine Marie Utter, reporting

43. ROUTINE144PTC THERAPEUTICS, INC.PTCTJun 22

    Neil Gregory Almstead, planned sale of PTCT shares

    Neil Gregory Almstead, reporting

44. ROUTINE8-KPTC THERAPEUTICS, INC.PTCTJun 18

    Current report

45. ROUTINE144PTC THERAPEUTICS, INC.PTCTJun 17

    Mark Elliott Boulding, planned sale of PTCT shares

    Mark Elliott Boulding, reporting

Older filings on EDGAR